story of the week
Effects of GLP-1 Receptor Agonists on Kidney and Cardiovascular Disease Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Lancet Diabetes Endocrinol 2024 Nov 25;[EPub Ahead of Print], SV Badve, A Bilal, MMY Lee, N Sattar, HC Gerstein, CT Ruff, JJV McMurray, P Rossing, G Bakris, KW Mahaffey, JFE Mann, HM Colhoun, KR Tuttle, RE Pratley, V PerkovicFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.